We are live on ! Find out more
ABEO icon

Abeona Therapeutics
ABEO

92 hedge funds and large institutions have $585M invested in Abeona Therapeutics in 2018 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 37 increasing their positions, 22 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

112% more call options, than puts

Call options by funds: $9.11M | Put options by funds: $4.3M

68% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 22

33% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 12

24% more capital invested

Capital invested by funds: $471M → $585M (+$114M)

5% more funds holding

Funds holding: 88 → 92 (+4)

0.31% more ownership

Funds ownership: 2.78% → 3.09% (+0.31%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
92
Holders Change
+4
Holders Change %
+4.55%
% of All Funds
2.11%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
16
Increased
37
Reduced
22
Closed
12
Calls
$9.11M
Puts
$4.3M
Net Calls
+$4.81M
Net Calls Change
+$1.78M

Top Buyers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$42.2M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$40M
3
State Street
State Street
Massachusetts
+$11.4M
4
PC
PointState Capital
New York
+$10.1M
5
Wellington Management Group
Wellington Management Group
Massachusetts
+$6.96M

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$27.9M
2
PA
Perceptive Advisors
New York
-$16.4M
3
Viking Global Investors
Viking Global Investors
Connecticut
-$11.9M
4
HCM
Highbridge Capital Management
New York
-$6.1M
5
UBS Group
UBS Group
Switzerland
-$2.63M
Name Holding Trade Value Shares
Change 		Change in
Stake
AIP
76
Ameritas Investment Partners
Nebraska
$43K +$10.1K +23 +27%
Zurich Cantonal Bank
77
Zurich Cantonal Bank
Switzerland
$30K +$32.8K +75 New
PCM
78
Prelude Capital Management
New York
$25K +$437 +1 +2%
UBS Group
79
UBS Group
Switzerland
$24K -$2.63M -6,023 -99%
BNP Paribas Financial Markets
80
BNP Paribas Financial Markets
France
$19.8K -$80K -183 -79%
Macquarie Group
81
Macquarie Group
Australia
$18K +$19.2K +44 New
LTFS
82
Ladenburg Thalmann Financial Services
Florida
$15K – – –
Victory Capital Management
83
Victory Capital Management
Texas
$15K – – –
PIA
84
Piedmont Investment Advisors
North Carolina
$9K +$9.18K +21 New
AG
85
Advisor Group
Arizona
$8K – – –
APA
86
American Portfolios Advisors
New York
$8K – – –
SPIA
87
Steward Partners Investment Advisory
New York
$6K – – –
TDC
88
Thompson Davis & Co
Virginia
$6K +$4.37K +10 +200%
WAS
89
Winch Advisory Services
Wisconsin
$5K +$5.24K +12 New
Bank of Montreal
90
Bank of Montreal
Ontario, Canada
$4K -$171K -391 -98%
Northwestern Mutual Wealth Management
91
Northwestern Mutual Wealth Management
Wisconsin
$3K – – –
MAM
92
Meeder Asset Management
Ohio
$240 +$437 +1 New
HCM
93
Highbridge Capital Management
New York
– -$6.1M -17,000 Closed
JGC
94
J. Goldman & Co
New York
– -$2.12M -5,907 Closed
KAM
95
Kavi Asset Management
New York
– -$1.25M -3,508 Closed
Hudson Bay Capital Management
96
Hudson Bay Capital Management
Connecticut
– -$864K -2,408 Closed
TI
97
Trexquant Investment
Connecticut
– -$260K -725 Closed
KeyBank National Association
98
KeyBank National Association
Ohio
– -$197K -548 Closed
SM
99
Sabby Management
Florida
– -$187K -520 Closed
VRS
100
Virginia Retirement Systems
Virginia
– -$152K -424 Closed
1 2 3
4
5

ABEO Hedge Fund Activity: Q2 2018 in Review

92 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics (ABEO) for Q2 2018, worth a combined $585M — up 24% from $471M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new ABEO positions and 12 closed out — a net gain of 4 holders — while 37 added to existing stakes and 22 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $42.2M. The largest seller was Citadel Advisors, cutting an estimated $27.9M.

  • 92 institutional investors held Abeona Therapeutics (ABEO) as of Q2 2018, up from 88 in Q1 2018.
  • Funds reported $585M of Abeona Therapeutics stock for Q2 2018, up 24% quarter-over-quarter.
  • 16 funds opened new Abeona Therapeutics positions in Q2 2018 and 12 closed out, a net change of +4 holders.
  • The largest Abeona Therapeutics buyer in Q2 2018 was T. Rowe Price Associates, an estimated $42.2M added.
  • The largest Abeona Therapeutics seller in Q2 2018 was Citadel Advisors, an estimated $27.9M sold.

Based on aggregated 13F filings for Q2 2018.